Organization Overview
Historical Acquisition Tree
Alternative names
Key: Asahi Kasei Pharma (0) Acquired (8)
Key: Asahi Kasei Pharma (6) Acquired (3)
Key: Asahi Kasei Pharma (3) Acquired (1)
Key: Asahi Kasei Pharma (2) Acquired (3)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Blood Coagulation Disorders (Phase 3)
Colonic Neoplasms (Phase 2)
Constriction, Pathologic (Phase 1)
Contracture (Phase 3)
Disseminated Intravascular Coagulation (Phase 4)
Dupuytren Contracture (Phase 3)
Fibrosis (Phase 3)
Hemiplegia (Phase 2)
Hemostatic Disorders (Phase 3)
Idiopathic Pulmonary Fibrosis (Phase 3)
Lupus Nephritis (Phase 3)
Mycoses (Phase 3)
Nephritis (Phase 3)
Nephrosis (Phase 3)
Nephrotic Syndrome (Phase 3)
Osteoporosis (Phase 3)
Peripheral Nervous System Diseases (Phase 2)
Pulmonary Fibrosis (Phase 3)
Sepsis (Phase 3)
Spinal Stenosis (Phase 1)
Spondylolisthesis (Phase 1)
Syndrome (Phase 3)
Toxemia (Phase 3)